Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Clinitech LaboratoryBOM:544220 -7.50%38 Days Payable is 96.79 as of Mar. 2026, which is 4% below its 10-year median of 100.67. GuruFocus rates BOM:544220 with a GF Score™ of 38/100. The stock has 6 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Clinitech Laboratory ranks better than 55.26% on this metric.
The historical rank and industry rank for Clinitech Laboratory's Days Payable or its related term are showing as below:
BOM:544220'
s Days Payable Range Over the Past 10 Years
Min: 78.66 Med: 100.67 Max: 130.07
Current: 80.99
During the past 6 years, Clinitech Laboratory's highest Days Payable was 130.07. The lowest was 78.66. And the median was 100.67.
BOM:544220's Days Payable is ranked better than 55.26% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 65.005
vs BOM:544220: 80.99
Clinitech Laboratory's Days Payable
declined
from Mar. 2025 (107.03) to Mar. 2026 (96.79).
It may suggest that Clinitech Laboratoryaccelerated paying its suppliers.
The historical data trend for Clinitech Laboratory's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544220 vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Clinitech Laboratory's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clinitech Laboratory Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Clinitech Laboratory's Days Payable distribution charts can be found below:
* The bar in red indicates where Clinitech Laboratory's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Clinitech Laboratory's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clinitech Laboratory (BOM:544220) has a Days Payable of 96.79 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Clinitech Laboratory and its competitors. This is near median its historical median of 100.67. Over the past decade, Clinitech Laboratory's Days Payable has ranged from 78.66 to 130.07. According to the industry distribution chart, Clinitech Laboratory ranks #85 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 44.7%.
Is Clinitech Laboratory's Days Payable too high?
Clinitech Laboratory's current Days Payable of 96.79 is near median its 10-year median of 100.67. Over the past 10 years, this metric has ranged from a low of 78.66 to a high of 130.07. The Medical Diagnostics & Research industry median Days Payable is 65.01. Clinitech Laboratory's value of 96.79 is 48.9% above this industry median. Based on the distribution chart, Clinitech Laboratory ranks #85 out of 190 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Clinitech Laboratory has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Clinitech Laboratory's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Clinitech Laboratory ranks #85 out of 190 companies for Days Payable. This puts Clinitech Laboratory in the upper half of its industry. The industry median Days Payable is 65.01. Clinitech Laboratory's value of 96.79 is 48.9% above this benchmark. Historically, Clinitech Laboratory's own Days Payable has ranged from 78.66 to 130.07 over the past decade. While the company's 10-year median is 100.67 vs. the industry median of 65.01, Clinitech Laboratory has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 65.01, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clinitech Laboratory's current Days Payable of 96.79 is 48.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Clinitech Laboratory and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 65.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clinitech Laboratory's current Days Payable is 96.79, which is near median its own 10-year median of 100.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinitech Laboratory stock overvalued right now?
Clinitech Laboratory (BOM:544220) has a current Days Payable of 96.79. The current Days Payable is 96.79, which is near median its 10-year median of 100.67 and 48.9% above the Medical Diagnostics & Research industry median of 65.01. Clinitech Laboratory's overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Clinitech Laboratory (BOM:544220), the current Days Payable is 96.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Clinitech Laboratory Ltd is an Indian diagnostic and healthcare services provider company. It operates a network of diagnostic centers in Thane and Navi Mumbai and offers various medical tests across multiple specialties, including biochemistry, immunology, hematology, molecular biology, serology, microbiology, and histopathology. It serves individual patients as well as corporate clients, aiming to provide affordable and comprehensive diagnostic solutions.
38GF Score
Get the complete analysis for BOM:544220
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544220 has been successfully added to your 
